From Startup to Scale: Dr. Therese Canares on Selling While Navigating the FDA Approval Process
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
Summary
In this conversation, Therese Canaris, CEO of Curie DX, discusses the innovative approach her company is taking to improve access to diagnostic tests in healthcare. She shares insights on the challenges of sales in the healthcare sector, the importance of customer discovery, and the need for building trust with healthcare providers. The conversation also touches on the complexities of navigating FDA approval, ensuring data security, and demonstrating the value and ROI of healthcare innovations.
Takeaways
- Curie DX aims to improve access to diagnostic tests.
- Sales in healthcare requires understanding customer needs.
- Customer discovery is crucial for product development.
- Building trust with healthcare providers is essential.
- Demonstrating ROI is a key challenge in healthcare sales.
- Navigating FDA approval is a lengthy process.
- Data security and HIPAA compliance are critical.
- Moms often make healthcare decisions for families.
- Innovative solutions can drive patient traffic to providers.
- The healthcare landscape is evolving with new regulations.
Todavía no hay opiniones